Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +50.33%
#3 Black Phoenix Black Phoenix +34.86%
#4 Velvet Velvet +32.55%
#5 Akedo Akedo +22.72%
#6 Fake World Assets Fake World Assets +19.66%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.95%
#8 DoubleZero DoubleZero +16.74%
#9 Palladium Network Palladium Network +15.82%
#10 clBTC clBTC +11.69%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Kedudukan dalam Saham #39914
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Harga Saham
$0.00366968
Disegerakkan terakhir: 2024-07-12
Modal Pasaran
$299.46K
Perubahan (1 hari)
-66.77%
Perubahan (1 tahun)
0.00%
Negara
CA
Perdagangan Biocure Technology Inc. (CURE)

Kategori

Healthcare
Pendapatan untuk Biocure Technology Inc. (CURE)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Biocure Technology Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Biocure Technology Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE